
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
Matej Sova, Luciano Saso
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 3181-3197
Open Access | Times Cited: 90
Matej Sova, Luciano Saso
Drug Design Development and Therapy (2018) Vol. Volume 12, pp. 3181-3197
Open Access | Times Cited: 90
Showing 1-25 of 90 citing articles:
Redox regulation of immunometabolism
Jonathan Muri, Manfred Köpf
Nature reviews. Immunology (2020) Vol. 21, Iss. 6, pp. 363-381
Closed Access | Times Cited: 357
Jonathan Muri, Manfred Köpf
Nature reviews. Immunology (2020) Vol. 21, Iss. 6, pp. 363-381
Closed Access | Times Cited: 357
Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review
Zahra Memariani, Syed Qamar Abbas, Syed Shams ul Hassan, et al.
Pharmacological Research (2020) Vol. 171, pp. 105264-105264
Closed Access | Times Cited: 174
Zahra Memariani, Syed Qamar Abbas, Syed Shams ul Hassan, et al.
Pharmacological Research (2020) Vol. 171, pp. 105264-105264
Closed Access | Times Cited: 174
Recent Advances of Natural Polyphenols Activators for Keap1‐Nrf2 Signaling Pathway
Yanping Zhou, Zhongliang Jiang, Haiying Lu, et al.
Chemistry & Biodiversity (2019) Vol. 16, Iss. 11
Closed Access | Times Cited: 164
Yanping Zhou, Zhongliang Jiang, Haiying Lu, et al.
Chemistry & Biodiversity (2019) Vol. 16, Iss. 11
Closed Access | Times Cited: 164
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 110
Pelin Telkoparan‐Akillilar, Emiliano Panieri, Dilek Cevik, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 110
An update of Nrf2 activators and inhibitors in cancer prevention/promotion
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103
Farhad Pouremamali, Amir Pouremamali, Mehdi Dadashpour, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103
Honey Bee Products: Preclinical and Clinical Studies of Their Anti-inflammatory and Immunomodulatory Properties
Hesham R. El‐Seedi, Nehal Eid, Aida A. Abd El‐Wahed, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 90
Hesham R. El‐Seedi, Nehal Eid, Aida A. Abd El‐Wahed, et al.
Frontiers in Nutrition (2022) Vol. 8
Open Access | Times Cited: 90
Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice
Tianming Zhao, Zihan Yu, Lei Zhou, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Tianming Zhao, Zihan Yu, Lei Zhou, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 72
Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
Javad Sharifi‐Rad, Véronique Seidel, Michalak Izabela, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Javad Sharifi‐Rad, Véronique Seidel, Michalak Izabela, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 54
The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 27
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 27
Nanomaterials‐Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy
Xumeng Wu, Ziqi Zhou, Kai Li, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 27
Xumeng Wu, Ziqi Zhou, Kai Li, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 27
Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130
Redox Potential of Antioxidants in Cancer Progression and Prevention
Sajan D. George, Heidi Abrahamse
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1156-1156
Open Access | Times Cited: 126
Sajan D. George, Heidi Abrahamse
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1156-1156
Open Access | Times Cited: 126
Cannabidiol Regulates the Expression of Keratinocyte Proteins Involved in the Inflammation Process through Transcriptional Regulation
Anna Jastrząb, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Cells (2019) Vol. 8, Iss. 8, pp. 827-827
Open Access | Times Cited: 102
Anna Jastrząb, Agnieszka Gęgotek, Elżbieta Skrzydlewska
Cells (2019) Vol. 8, Iss. 8, pp. 827-827
Open Access | Times Cited: 102
The role of natural products in revealing NRF2 function
Donna D. Zhang, Eli Chapman
Natural Product Reports (2020) Vol. 37, Iss. 6, pp. 797-826
Open Access | Times Cited: 99
Donna D. Zhang, Eli Chapman
Natural Product Reports (2020) Vol. 37, Iss. 6, pp. 797-826
Open Access | Times Cited: 99
The Nrf2 Pathway in Ischemic Stroke: A Review
Marcelo Farina, Leonardo Eugênio Vieira, Brigitta Buttari, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 5001-5001
Open Access | Times Cited: 94
Marcelo Farina, Leonardo Eugênio Vieira, Brigitta Buttari, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 5001-5001
Open Access | Times Cited: 94
Ellagic Acid-Derived Urolithins as Modulators of Oxidative Stress
Jasmina Djedjibegovíc, Aleksandra Marjanović, Emiliano Panieri, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 91
Jasmina Djedjibegovíc, Aleksandra Marjanović, Emiliano Panieri, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 91
Carbosilane Dendrimers Loaded with siRNA Targeting Nrf2 as a Tool to Overcome Cisplatin Chemoresistance in Bladder Cancer Cells
Leanne Ambrosio, Monica Argenziano, Marie Angèle Cucci, et al.
Antioxidants (2020) Vol. 9, Iss. 10, pp. 993-993
Open Access | Times Cited: 90
Leanne Ambrosio, Monica Argenziano, Marie Angèle Cucci, et al.
Antioxidants (2020) Vol. 9, Iss. 10, pp. 993-993
Open Access | Times Cited: 90
Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
Bercis İmge Uçar, Gülberk Uçar, Sarmistha Saha, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 823-823
Open Access | Times Cited: 82
Bercis İmge Uçar, Gülberk Uçar, Sarmistha Saha, et al.
Antioxidants (2021) Vol. 10, Iss. 6, pp. 823-823
Open Access | Times Cited: 82
Hepatoprotective, antioxidant and, anti-inflammatory potentials of gallic acid in carbon tetrachloride-induced hepatic damage in Wistar rats
Sam I. Ojeaburu, Kelly Oriakhi
Toxicology Reports (2021) Vol. 8, pp. 177-185
Open Access | Times Cited: 73
Sam I. Ojeaburu, Kelly Oriakhi
Toxicology Reports (2021) Vol. 8, pp. 177-185
Open Access | Times Cited: 73
A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies
Síbel Süzen, Paolo Tucci, Elisabetta Profumo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 692-692
Open Access | Times Cited: 47
Síbel Süzen, Paolo Tucci, Elisabetta Profumo, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 692-692
Open Access | Times Cited: 47
Natural Nrf2 Inhibitors: A Review of Their Potential for Cancer Treatment
Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3029-3041
Open Access | Times Cited: 35
Juan Zhang, Hong‐Xi Xu, Jiaqian Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 10, pp. 3029-3041
Open Access | Times Cited: 35
Expected and Unexpected Effects of Pharmacological Antioxidants
Irina Tyuryaeva, O. G. Lyublinskaya
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9303-9303
Open Access | Times Cited: 25
Irina Tyuryaeva, O. G. Lyublinskaya
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9303-9303
Open Access | Times Cited: 25
Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe
Xiaofei Fan, Lin Lin, Binxin Cui, et al.
Pharmacological Research (2020) Vol. 159, pp. 104945-104945
Closed Access | Times Cited: 65
Xiaofei Fan, Lin Lin, Binxin Cui, et al.
Pharmacological Research (2020) Vol. 159, pp. 104945-104945
Closed Access | Times Cited: 65
Nrf2 Involvement in Chemical-Induced Skin Innate Immunity
Doumet Georges Helou, Stefan F. Martin, Marc Pallardy, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 61
Doumet Georges Helou, Stefan F. Martin, Marc Pallardy, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 61